choroid plexus carcinoma (Cancer)
Information
- Disease name
- choroid plexus carcinoma
- Disease ID
- DOID:5648
- Description
- "A choroid plexus cancer that has_material_basis_in epithelial cells of the choroid plexus." [url:http\://en.wikipedia.org/wiki/Carcinoma, url:http\://en.wikipedia.org/wiki/Choroid_plexus_carcinoma, url:http\://www.cancer.gov/dictionary?CdrID=45963]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05934630 | Active, not recruiting | Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors | July 12, 2023 | July 12, 2028 | |
| NCT03500991 | Active, not recruiting | Phase 1 | HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors | July 26, 2018 | July 26, 2039 |
| NCT03638167 | Active, not recruiting | Phase 1 | EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors | March 19, 2019 | March 2040 |
| NCT03434262 | Completed | Phase 1 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | March 5, 2018 | May 24, 2024 |
| NCT04185038 | Recruiting | Phase 1 | Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors | December 11, 2019 | May 2041 |
| NCT03050268 | Recruiting | Familial Investigations of Childhood Cancer Predisposition | April 6, 2017 | March 31, 2037 | |
| NCT04994977 | Recruiting | Phase 1 | Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery | May 4, 2023 | December 2026 |
| NCT04521946 | Withdrawn | Phase 1 | Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer | January 14, 2021 | December 20, 2022 |
- Disase is a (Disease Ontology)
- DOID:3540
- Cross Reference ID (Disease Ontology)
- GARD:8238
- Cross Reference ID (Disease Ontology)
- ICDO:9390/3
- Cross Reference ID (Disease Ontology)
- MESH:C562943
- Cross Reference ID (Disease Ontology)
- NCI:C4533
- Cross Reference ID (Disease Ontology)
- NCI:C4715
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:1156471001
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:188292007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0346289
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0431109
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030392
- OrphaNumber from OrphaNet (Orphanet)
- 251899